Microbubbles/Ultrasound Contrast Agents Market
The Global microbubbles/ultrasound contrast agents market will grow at a CAGR of 25.2% from 2018 to 2024 to reach USD 1,584.5 million by 2024, according to the latest publication from Meticulous Research®. The global microbubbles/ultrasound contrast agents market is driven by various factors such as advancement in ultrasound technologies, benefits of ultrasound over alternative technologies, increase in demand for diagnostics & image guided procedures, favorable reimbursement policies for contrast enhanced procedures in the U.S., and growing aging population and subsequent rise in the prevalence of chronic diseases. In addition, rising research activities related to microbubbles/ultrasound contrast agents and emerging economies in the Asia Pacific region provides significant opportunities for various stakeholders in this market.
Key market segments to
watch
The global
microbubbles/ultrasound contrast agents market studied in this report is majorly
segmented on the basis of therapeutic area (cardiovascular diseases, renal and
associated diseases, and others), application (molecular imaging, gene therapy,
drug delivery, and stem cells delivery), and geography.
On the basis of
therapeutic area, cardiovascular diseases commanded the largest share in the
global microbubbles/ultrasound contrast agents market in 2017, mainly due to
rising adoption of ultrasound contrast agents in echocardiography procedures
with increasing prevalence of chronic cardiovascular diseases, rising mortality
associated to stroke and heart attack, and need for better diagnosis
technology.
On the basis of
applications, molecular imaging held the largest share in the
microbubbles/ultrasound contrast agents market in 2017. This was mainly
attributed to rising adoption of microbubbles in various ultrasound based
molecular imaging procedures for the accurate diagnosis of various diseases. In
addition, increasing need for monitoring of the biomarker status of vascular
endothelium, visualizing tumor vasculature, imaging inflammation and
ischemia-reperfusion injury zones, and need for targeted therapies further
propels the adoption of microbubbles in molecular imaging applications.
Regional market growth
trends
Geographically, this
market is segmented into North America, Europe, Asia Pacific, and rest of the
World. North America commanded the largest share in the global
microbubbles/ultrasound contrast agents market in 2017, followed by Europe and
Asia-Pacific. The major share of this region is mainly attributed to the rising
aging population, increasing number of chronic diseases, well-established
healthcare system with wide spread chain of suppliers & distributors,
higher adoption of innovative technologies, rising technological advancements
in healthcare, and higher healthcare spending in the region, especially in the
U.S. However, Asia pacific region is slated to register the fastest growth
during the forecast period, primarily due to rising healthcare spending,
improving healthcare infrastructure, rising living standards with increasing
income of middle class population, growing healthcare awareness, and growing
aging population and subsequently prevalence of chronic diseases in the Asian
countries.
Key players in the global
market
The key players in the
global microbubbles/ultrasound contrast agents market are Lantheus Holdings,
Inc., Bracco, GE Healthcare, Daiichi Sankyo Company, Limited, and nanoPET
Pharma GmbH. These vendors employed various strategies to expand their product
and application offerings, global footprint, and augment their market shares.
About Meticulous Research®
Meticulous Research® is
founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in
2013 as a private limited company under the Companies Act, 1956. Since its
incorporation, the company has become the leading provider of premium market
intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle
East & Africa.
Contact
Us:
Viren Shrivastava
Viren Shrivastava
AVP-
Global Sales and Marketing
Meticulous
Research®
Tel:
+1-646-781-8004
Email:
viren@meticulousresearch.com
Comments
Post a Comment